PDP1 and breast cancer: Importantly, these results visibly support the presence of two different metabophenotypes: the PDH predominant phenotype displaying stronger reliance on TCA activity in MDA-MB-231 triple negative breast cancer cells and the phenotype showing larger PC activity that is associated with a stronger dependence on glycolysis in MCF7 hormone receptor-positive breast cancer cells.